Shareholders Services (Elementor)

Corporate Profile

WinSanTor Inc. is a private, clinical-stage biotechnology company focused on the discovery and development of treatments for peripheral neuropathies, including diabetic peripheral neuropathy, chemo and HIV-induced peripheral neuropathy, and others. WinSanTor is currently studying its lead drug, WST-057, in a Phase 2 clinical trial in Canada for the treatment of human patients with diabetic peripheral neuropathy. Our research has been supported by leading stakeholders in the field, including the Juvenile Diabetes Research Foundation, National Institute of Diabetes and Digestive and Kidney Diseases (at the National Institutes of Health) and the Canadian Institutes of Health Research. We are headquartered in San Diego, California.